HopeStage
Back to overview

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Topics
More filters

Some studies do not list a clear city. Always confirm the location with the study team.

Some visits may still be in person. Participation depends on the study’s location and eligibility requirements.

4317studies shown
Showing 157-168 of 4,317
Drug study icon
RecruitingACTRN12625000942459

A crossover study to investigate the safety, tolerability, pharmacokinetics, relative bioavailability, and pharmacodynamics of single doses of Katamine immediate release (KET-IR) and Ketamine abuse deterrent (KET-AD) oral ketamine capsules in healthy volunteers.

Official study title

A randomised open-label crossover study to investigate the safety, tolerability, pharmacokinetics, relative bioavailability, and pharmacodynamics of single doses of Katamine immediate release (KET-IR) and Ketamine abuse deterrent (KET-AD) oral ketamine capsules in healthy volunteers.

In Australia
BipolarityInterventional studyAges 18–55
Countries
Australia
Sponsor
Novotech (Australia) Pty Limited
Drug study icon
RecruitingACTRN12626000404325

LactoSpore for Depression

Official study title

A randomised, double-blind, placebo-controlled clinical study to evaluate the efficacy and safety of LactoSpore (Heyndrickxia coagulans MTCC 5856) in perimenopausal women.

In Australia
Depression, AnxietyInterventional studyAges 40–55
Countries
Australia
Sponsor
Clinical Research Australia
Drug study icon
RecruitingACTRN12626000393358

A study Investigating the Effects of Vanizem (Aframomum melegueta seeds extract) on Stress, Anxiety, Sleep, and Mood in Adults with Mild-to-Moderate Stress.

Official study title

A Randomised, Double-Blind, Placebo-Controlled Trial Investigating the Effects of Vanizem (Aframomum melegueta seeds extract) on Stress, Anxiety, Sleep, and Mood in Adults with Mild-to-Moderate Stress.

In Australia
AnxietyInterventional studyAges 18–60
Countries
Australia
Sponsor
Clinical Research Australia
Device study icon
RecruitingNCT06005103

Active or sham MoodHeadBand treatment for depression

About this title

A Randomized Clinical Trial Comparing Active Versus Sham T-PEMF Headband Treatment for Depression

Read the official source — NCT06005103
Official study title

Active Versus Sham Transcranial Pulsed Electromagnetic Field Headband Treatment for Major Depression: a Study Protocol for a Double-blinded Randomized Trial

In Frederiksberg
Depression, SchizophreniaDevice studyAges 18–65
Countries
Denmark
Sponsor
Mental Health Centre Copenhagen, Bispebjerg and Frederiksberg Hospital
Behavioral study icon
RecruitingNCT06115746

iDECIDE drug education for middle and high school students

About this title

A Randomized Clinical Trial of a Novel Drug Education and Diversion Program (iDECIDE) for Middle and High School Students

Read the official source — NCT06115746
Official study title

A Randomized Clinical Trial of a Novel Drug Education and Diversion Program (iDECIDE) for Middle and High School Students

In Boston
AddictionBehavioural studyAges 9–22
Countries
United States
Sponsor
Massachusetts General Hospital (Hospital / academic medical center)
Other study type icon
RecruitingACTRN12614001053617

A study to determine the efficacy of Affron, a standardised extract of Saffron (Crocus sativus) on mood and cognitive function in healthy adults over 4 weeks.

Official study title

A randomized clinical trial to determine the efficacy of Affron, a standardised extract of Saffron (Crocus sativus) on mood and cognitive function in healthy adults over 4 weeks.

In Australia
Mental healthInterventional studyAges 16–75
Countries
Australia
Sponsor
Integrated Health Group Pty. Ltd.
Behavioral study icon
RecruitingNCT05943171

Digital avatar CBT or therapist CBT for substance use and partner-violence concerns

About this title

A Randomized Controlled Trial of Digital CBT to Treat Addiction: Digital RITch®CBT vs. Standard CBT

Read the official source — NCT05943171
Official study title

A Randomized Controlled Trial of A Digital, Self-Guided, Avatar Assisted- Cognitive Behavioral Therapy Platform to Treat Addiction: RITch®CBT vs. Treatment As Usual

In Rochester
AddictionDevice studyAges 18–65
Countries
United States
Sponsor
University of Rochester

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.